The Cigna Group (NYSE:CI) Shares Sold by Kiltearn Partners LLP

Kiltearn Partners LLP trimmed its holdings in shares of The Cigna Group (NYSE:CI) by 1.1% during the 4th quarter, Holdings Channel reports. The institutional investor owned 101,300 shares of the health services provider’s stock after selling 1,100 shares during the period. The Cigna Group comprises 4.6% of Kiltearn Partners LLP’s holdings, making the stock its 7th largest holding. Kiltearn Partners LLP’s holdings in The Cigna Group were worth $27,973,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. TCTC Holdings LLC acquired a new stake in shares of The Cigna Group during the fourth quarter worth $25,000. Collier Financial purchased a new position in The Cigna Group in the 4th quarter worth $32,000. ORG Wealth Partners LLC acquired a new stake in shares of The Cigna Group during the fourth quarter worth about $34,000. Compagnie Lombard Odier SCmA purchased a new stake in The Cigna Group in the fourth quarter valued at approximately $37,000. Finally, Heck Capital Advisors LLC acquired a new position in The Cigna Group in the 4th quarter worth approximately $53,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, insider Nicole S. Jones sold 4,904 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $1,511,020.48. Following the completion of the sale, the insider now owns 29,421 shares of the company’s stock, valued at $9,065,198.52. This represents a 14.29 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Elder Granger sold 2,376 shares of the company’s stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $310.35, for a total value of $737,391.60. Following the completion of the transaction, the director now owns 5,471 shares in the company, valued at $1,697,924.85. This represents a 30.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 43,751 shares of company stock worth $13,603,991. 0.60% of the stock is owned by insiders.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Wells Fargo & Company cut their price objective on shares of The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating on the stock in a research note on Tuesday, February 4th. Oppenheimer decreased their price objective on The Cigna Group from $400.00 to $375.00 and set an “outperform” rating for the company in a report on Friday, January 31st. Royal Bank of Canada set a $355.00 target price on The Cigna Group in a research note on Friday, January 31st. Piper Sandler reiterated an “overweight” rating and set a $348.00 price target (down from $394.00) on shares of The Cigna Group in a research report on Monday, February 3rd. Finally, Stephens lowered their price objective on The Cigna Group from $410.00 to $380.00 and set an “overweight” rating on the stock in a research report on Friday, January 31st. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and a consensus price target of $373.25.

The Cigna Group Price Performance

NYSE:CI opened at $324.74 on Friday. The stock has a 50 day moving average of $303.86 and a two-hundred day moving average of $314.31. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The firm has a market cap of $88.88 billion, a P/E ratio of 26.53, a price-to-earnings-growth ratio of 0.98 and a beta of 0.53. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70.

The Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period last year, the company earned $6.79 earnings per share. On average, analysts expect that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th were paid a $1.51 dividend. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a dividend yield of 1.86%. The ex-dividend date was Wednesday, March 5th. The Cigna Group’s dividend payout ratio (DPR) is currently 49.35%.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.